Cejun Yang
Overview
Explore the profile of Cejun Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu M, Li L, Cao L, Li W, Gu X, Yang M, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39988347
Background: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide, especially in advanced stages where limited treatment options result in poor prognosis. The immunosuppressive tumor immune microenvironment (TIME),...
2.
Zhu Y, Li J, Li S, Yang Z, Qiao Z, Gu X, et al.
Cell Commun Signal
. 2024 Aug;
22(1):407.
PMID: 39164737
Dysregulation of splicing factor expression plays a crucial role in the progression of hepatocellular carcinoma (HCC). Our research found that the expression level of splicing factor ZMAT2 was increased in...
3.
Li J, Wang W, Li S, Qiao Z, Jiang H, Chang X, et al.
Cancer Cell Int
. 2024 May;
24(1):176.
PMID: 38769521
Background: Hepatocellular carcinoma (HCC) represents one of the most significant causes of mortality due to cancer-related deaths. It has been previously reported that the TGF-β signaling pathway may be associated...
4.
Cao L, Ma X, Zhang J, Yang C, Rong P, Wang W
Discov Oncol
. 2023 Jul;
14(1):134.
PMID: 37470852
Introduction: PTEN often mutates in tumors, and its manipulation is suggested to be used in the development of preclinical tools in cancer research. This study aims to explore the biological...
5.
Yang C, Wang W, Li S, Qiao Z, Ma X, Yang M, et al.
Front Immunol
. 2023 Mar;
14:1113385.
PMID: 36960059
Instruction: Ulcerative colitis (UC) can cause a variety of immune-mediated intestinal dysfunctions and is a significant model of inflammatory bowel disease (IBD). Colorectal cancer (CRC) mostly occurs in patients with...
6.
Cao L, Ma X, Zhang J, Yang M, He Z, Yang C, et al.
Cell Transplant
. 2023 Jan;
32:9636897221149444.
PMID: 36644879
Clinically, xenotransplantation often leads to T-cell-mediated graft rejection. Immunosuppressive agents including polyclonal regulatory T cells (poly-Tregs) promote global immunosuppression, resulting in serious infections and malignancies in patients. Xenoantigen-expanded Tregs (xeno-Tregs)...
7.
Chen Y, Yang C, Mao J, Li H, Ding J, Zhou W
RSC Adv
. 2022 May;
9(20):11026-11037.
PMID: 35520220
Tumor targeting delivery of chemotherapeutic drugs by nanocarriers has been demonstrated to be a promising strategy for cancer therapy with improved therapeutic efficacy. In this work, we reported a novel...
8.
Zhang J, Ma X, Cao L, He X, Li S, Yang M, et al.
Clin Exp Immunol
. 2022 Apr;
208(3):255-267.
PMID: 35439818
FOXP3+ regulatory T cells (Tregs) are central to maintaining peripheral tolerance and immune homeostasis. They have the potential to be developed as a cellular therapy to treat various clinical ailments...
9.
He X, Li S, Zhang J, Cao L, Yang C, Rong P, et al.
Cell Transplant
. 2021 Sep;
30:9636897211046556.
PMID: 34570631
The role of Regulatory T cells (Tregs) in tolerance induction post-transplantation is well-established, but Tregs adoptive transfer alone without combined immunosuppressants have failed so far in achieving clinical outcomes. Here...
10.
Li H, Rong P, Ma X, Nie W, Chen C, Yang C, et al.
Life Sci
. 2018 Nov;
215:113-118.
PMID: 30399376
Diabetic nephropathy (DN) is a microvascular complication of diabetes mellitus (DM) and the main reason for end-stage renal diseases (ESRD). Based on the role of mesenchymal stem cells (MSCs) in...